Table 1.

Composition of the capsular group B meningococcal four component vaccine, 4CMenB.

Vaccine constituent	Quantity
Neisserial adhesin A (NadA) variant 3.1	50 μg
Factor H binding protein (fHbp) variant 1.1 (fused to GNA2091)	50 μg
Neisserial heparin binding antigen peptide ID 2 (fused to GNA1030)	50 μg
Outer membrane vesicles from the NZ98/254 strain	25 μg
Aluminium hydroxide	0.5 mg
Sodium chloride, histidine, sucrose, and water for injections	—

The final formulation of the 4CMenB vaccine as outlined by the European Medicines Agency⁵⁹.